FDA allows OTC of Sanofi’s Nasacort

10:37 EDT 13 Oct 2013 | thePharmaLetter

The US Food and Drug Administration has approved French drug major Sanofi’s Nasacort (triamcinolone) Allergy 24HR nasal spray as an over-the-counter treatment for seasonal and year-round nasal allergies in adults and children two years of age and o...

Original Article: FDA allows OTC of Sanofi’s Nasacort

NEXT ARTICLE

More From BioPortfolio on "FDA allows OTC of Sanofi’s Nasacort"

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - http://www.scrip100.com/scrip100.html) Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...

Advertisement

Searches Linking to this Story